This article is more than 5 years old. Information may no longer be current.

LDR launches ROI C Lordotic Cervical Cage in US market

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has granted 510(k) approval for LDR’s ROI-C Lordotic Cervical Cage.

When used with the company’s integrated VerteBRIDGE plating technology, both cages offer a zero profile, stand-alone construct for fusion in the cervical spine. According to a company press release, the design of the ROI-C Lordotic Cervical Cage allow surgeons to treat patients with more varied anatomy and reduces the need for thick cervical plates that may contribute to dysphagia.

“We are excited to strengthen our worldwide leadership in stand-alone device innovation by introducing the ROI-C Lordotic Cervical Cage into the U.S. market. LDR has led the way in providing surgeons with a broad selection of implant geometries for stand-alone cervical and lumbar fusions,” Christophe Lavigne, president and chief executive officer of LDR, stated in the release.